United States — California State Board of Pharmacy
Tracked across 2 events · 18 articles · First seen Jun 27, 2026 · Last active Aug 23, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: The United States — California State Board of Pharmacy issued an alert regarding Amgen's recall of Corlanor and Sensipar tablets, providing details on the foreign matter and the precautionary measures taken.
Jun 27, 2026 · 6 articles
Domestic
Fire and medical officials issued warnings about the supplement glutathione offered to Western wildland firefighters exposed to toxic chemicals during major wildfires. Glutathione, administered via IV or nebulizer, has not been proven safe or effective…
Impact: Reversed regulations that would have restricted glutathione access, a decision now under scrutiny given safety concerns. May face pressure to re-evaluate.
Aug 23, 2026 · 12 articles
60
United States — California State Board of Pharmacy reversed regulationsGlutathione supplement...
ERGEN INTELLIGENCE
Track United States — California State Board of Pharmacy live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard